Latest Insider Transactions at Denali Therapeutics Inc. (DNLI)
This section provides a real-time view of insider transactions for Denali Therapeutics Inc. (DNLI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Denali Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Denali Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
3,208
-2.2%
|
$60,952
$19.43 P/Share
|
|
Jan 05
2024
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
9,972
-4.78%
|
$189,468
$19.43 P/Share
|
|
Jan 05
2024
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
17,483
-0.76%
|
$332,177
$19.43 P/Share
|
|
Jan 05
2024
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
9,972
-1.82%
|
$189,468
$19.43 P/Share
|
|
Jan 03
2024
|
Ryan J. Watts President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
89,520
+24.7%
|
-
|
|
Jan 03
2024
|
Carole Ho Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,720
+24.85%
|
-
|
|
Jan 03
2024
|
Alexander O. Schuth COFO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
53,720
+24.0%
|
-
|
|
Dec 15
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.32%
|
$38,318
$23.39 P/Share
|
|
Nov 15
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.3%
|
$31,654
$19.13 P/Share
|
|
Oct 16
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.28%
|
$33,320
$20.66 P/Share
|
|
Sep 15
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.63%
|
$38,318
$23.98 P/Share
|
|
Aug 23
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,522
-0.48%
|
$58,006
$23.17 P/Share
|
|
Aug 23
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,522
-1.36%
|
$58,006
$23.22 P/Share
|
|
Aug 21
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,478
-1.32%
|
$54,516
$22.6 P/Share
|
|
Aug 21
2023
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
1,419
-0.96%
|
$31,218
$22.6 P/Share
|
|
Aug 21
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
2,309
-0.1%
|
$50,798
$22.59 P/Share
|
|
Aug 21
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,478
-0.47%
|
$54,516
$22.59 P/Share
|
|
Aug 15
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.25%
|
$39,984
$24.3 P/Share
|
|
Aug 14
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,768
-1.49%
|
$63,664
$23.79 P/Share
|
|
Aug 14
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,772
-0.53%
|
$63,756
$23.67 P/Share
|
|
Aug 10
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,853
-0.54%
|
$68,472
$24.18 P/Share
|
|
Aug 10
2023
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,857
-1.52%
|
$68,568
$24.15 P/Share
|
|
Aug 10
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
2,526
-0.11%
|
$63,150
$25.03 P/Share
|
|
Aug 10
2023
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,526
+0.11%
|
$0
$0.68 P/Share
|
|
Jul 18
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
9,702
-1.84%
|
$291,060
$30.01 P/Share
|
|
Jul 17
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-1.86%
|
$290,000
$29.6 P/Share
|
|
Jul 17
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+1.82%
|
$50,000
$5.28 P/Share
|
|
Jul 17
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.24%
|
$48,314
$29.6 P/Share
|
|
Jun 28
2023
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.61%
|
$48,314
$29.76 P/Share
|
|
Jun 16
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
50,000
-2.18%
|
$1,550,000
$31.4 P/Share
|
|
Jun 16
2023
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
50,000
+2.14%
|
$0
$0.68 P/Share
|
|
Jun 01
2023
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+21.35%
|
-
|
|
Jun 01
2023
|
Peter S Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+21.35%
|
-
|
|
Jun 01
2023
|
Marc Tessier Lavigne Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+0.22%
|
-
|
|
Jun 01
2023
|
Steve E. Krognes Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+2.78%
|
-
|
|
Jun 01
2023
|
Nancy Thornberry Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+24.9%
|
-
|
|
Jun 01
2023
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+3.0%
|
-
|
|
Jun 01
2023
|
Douglas G. Cole Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+13.7%
|
-
|
|
Jun 01
2023
|
Erik Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+27.55%
|
-
|
|
Jun 01
2023
|
Jay T Flatley Director |
BUY
Grant, award, or other acquisition
|
Indirect |
4,216
+1.22%
|
-
|
|
Jun 01
2023
|
David P Schenkein Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,216
+21.35%
|
-
|
|
May 15
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-0.93%
|
$280,000
$28.89 P/Share
|
|
May 15
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+1.82%
|
$50,000
$5.28 P/Share
|
|
Apr 21
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
24,800
-1.1%
|
$620,000
$25.15 P/Share
|
|
Apr 21
2023
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
24,800
+1.08%
|
$0
$0.68 P/Share
|
|
Apr 20
2023
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
200
-0.01%
|
$5,000
$25.0 P/Share
|
|
Apr 20
2023
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
200
+0.01%
|
$0
$0.68 P/Share
|
|
Apr 13
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
4,898
-0.92%
|
$122,450
$25.04 P/Share
|
|
Apr 13
2023
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,898
+0.91%
|
$24,490
$5.28 P/Share
|
|
Apr 12
2023
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
5,102
-0.96%
|
$127,550
$25.04 P/Share
|